DOAJ Open Access 2023

Melatonin Treatment in Kidney Diseases

Magdalena Markowska Stanisław Niemczyk Katarzyna Romejko

Abstrak

Melatonin is a neurohormone that is mainly secreted by the pineal gland. It coordinates the work of the superior biological clock and consequently affects many processes in the human body. Disorders of the waking and sleeping period result in nervous system imbalance and generate metabolic and endocrine derangements. The purpose of this review is to provide information regarding the potential benefits of melatonin use, particularly in kidney diseases. The impact on the cardiovascular system, diabetes, and homeostasis causes melatonin to be indirectly connected to kidney function and quality of life in people with chronic kidney disease. Moreover, there are numerous reports showing that melatonin plays a role as an antioxidant, free radical scavenger, and cytoprotective agent. This means that the supplementation of melatonin can be helpful in almost every type of kidney injury because inflammation, apoptosis, and oxidative stress occur, regardless of the mechanism. The administration of melatonin has a renoprotective effect and inhibits the progression of complications connected to renal failure. It is very important that exogenous melatonin supplementation is well tolerated and that the number of side effects caused by this type of treatment is low.

Topik & Kata Kunci

Penulis (3)

M

Magdalena Markowska

S

Stanisław Niemczyk

K

Katarzyna Romejko

Format Sitasi

Markowska, M., Niemczyk, S., Romejko, K. (2023). Melatonin Treatment in Kidney Diseases. https://doi.org/10.3390/cells12060838

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →
Lihat di Sumber doi.org/10.3390/cells12060838
Informasi Jurnal
Tahun Terbit
2023
Sumber Database
DOAJ
DOI
10.3390/cells12060838
Akses
Open Access ✓